Data on the hemostasis in epistaxis with Topically Administered TXA Versus Topical Oxymetazoline Spray
The use of tranexamic acid (TXA) has recently gained popularity as a treatment modality for epistaxis in the emergency department. Data are presented on the efficacy of the topical use of the intravenous formulation of TXA versus the vasoconstrictor oxymetazoline applied topically in achieving hemos...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-04-01
|
Series: | Data in Brief |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352340920301773 |
id |
doaj-4cf317d6f71a4b3b9cf4b7b17e495fd6 |
---|---|
record_format |
Article |
spelling |
doaj-4cf317d6f71a4b3b9cf4b7b17e495fd62020-11-25T03:21:44ZengElsevierData in Brief2352-34092020-04-0129Data on the hemostasis in epistaxis with Topically Administered TXA Versus Topical Oxymetazoline SprayKristen Whitworth0Jacob Johnson1Samuel Wisniewski2Meghan Schrader3Lakeland Health, United States; Corresponding author.Lakeland Health, United StatesMichigan State University College of Osteopathic Medicine, United StatesLakeland Health, United StatesThe use of tranexamic acid (TXA) has recently gained popularity as a treatment modality for epistaxis in the emergency department. Data are presented on the efficacy of the topical use of the intravenous formulation of TXA versus the vasoconstrictor oxymetazoline applied topically in achieving hemostasis in patient presenting to the emergency department with anterior epistaxis. The original article “Comparative Effectiveness of Topically Administered TXA Versus Topical Oxymetazoline Spray for Achieving Hemostasis in Epistaxis” [1] provides complete interpretation of the data. The dataset regarding these treatment modalities has clinical significance toward preventing an avoidable need for escalation of treatment that could potentially increase patient discomfort and prolong emergency department throughput time. Keywords: TXA, Tranexamic acid, Epistaxis, Oxymetazolinehttp://www.sciencedirect.com/science/article/pii/S2352340920301773 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Kristen Whitworth Jacob Johnson Samuel Wisniewski Meghan Schrader |
spellingShingle |
Kristen Whitworth Jacob Johnson Samuel Wisniewski Meghan Schrader Data on the hemostasis in epistaxis with Topically Administered TXA Versus Topical Oxymetazoline Spray Data in Brief |
author_facet |
Kristen Whitworth Jacob Johnson Samuel Wisniewski Meghan Schrader |
author_sort |
Kristen Whitworth |
title |
Data on the hemostasis in epistaxis with Topically Administered TXA Versus Topical Oxymetazoline Spray |
title_short |
Data on the hemostasis in epistaxis with Topically Administered TXA Versus Topical Oxymetazoline Spray |
title_full |
Data on the hemostasis in epistaxis with Topically Administered TXA Versus Topical Oxymetazoline Spray |
title_fullStr |
Data on the hemostasis in epistaxis with Topically Administered TXA Versus Topical Oxymetazoline Spray |
title_full_unstemmed |
Data on the hemostasis in epistaxis with Topically Administered TXA Versus Topical Oxymetazoline Spray |
title_sort |
data on the hemostasis in epistaxis with topically administered txa versus topical oxymetazoline spray |
publisher |
Elsevier |
series |
Data in Brief |
issn |
2352-3409 |
publishDate |
2020-04-01 |
description |
The use of tranexamic acid (TXA) has recently gained popularity as a treatment modality for epistaxis in the emergency department. Data are presented on the efficacy of the topical use of the intravenous formulation of TXA versus the vasoconstrictor oxymetazoline applied topically in achieving hemostasis in patient presenting to the emergency department with anterior epistaxis. The original article “Comparative Effectiveness of Topically Administered TXA Versus Topical Oxymetazoline Spray for Achieving Hemostasis in Epistaxis” [1] provides complete interpretation of the data. The dataset regarding these treatment modalities has clinical significance toward preventing an avoidable need for escalation of treatment that could potentially increase patient discomfort and prolong emergency department throughput time. Keywords: TXA, Tranexamic acid, Epistaxis, Oxymetazoline |
url |
http://www.sciencedirect.com/science/article/pii/S2352340920301773 |
work_keys_str_mv |
AT kristenwhitworth dataonthehemostasisinepistaxiswithtopicallyadministeredtxaversustopicaloxymetazolinespray AT jacobjohnson dataonthehemostasisinepistaxiswithtopicallyadministeredtxaversustopicaloxymetazolinespray AT samuelwisniewski dataonthehemostasisinepistaxiswithtopicallyadministeredtxaversustopicaloxymetazolinespray AT meghanschrader dataonthehemostasisinepistaxiswithtopicallyadministeredtxaversustopicaloxymetazolinespray |
_version_ |
1724612829429891072 |